Minutes for the Research for Patient Benefit Programme Under-represented disciplines and specialisms highlight notice: Methodologists Research Advisory Committee A Stage 1 meeting
Date and Location
Wednesday 6 December 2023 Via Zoom Virtual Meeting
In attendance
Committee Members
Professor Chris Gale (Chair)
Ms Catherine Arundel
Professor John Campbell
Professor Gary Collins
Professor Cindy Cooper
Professor David Cromwell
Professor Sofia Dias
Mr Stephen Edgar
Professor Lyn Ellett
Professor Laura Gray
Professor Richard Grieve
Professor William Hamilton
Professor Simon Heller
Dr Lisa Hinton
Professor Andrew Judge
Dr Anne Killett
Professor Jos Latour
Professor Marcus Munafo
Ms Stella O'Brien
Professor Steve Pilling
Dr Cath Quinn
Professor Judith Rankin
Professor Tom Sanders
Dr David Stephensen
Mr Steve Telford
Professor David Torgerson
Professor Andy Vail
Professor Bridget Young
Secretariat
Mr Simon Goodwin (NIHRCC)
Dr Heather Ford (NIHRCC)
Dr Jennie Hejdenberg (NIHRCC)
Dr Kasia Kuleszewicz (NIHRCC)
Mrs Zuzanna Tajchman (NIHRCC)
Mr Ian Beason (NIHRCC)
Ms Lavpeet Ranjit (NIHRCC)
Ms Alisha Singh (NIHRCC)
Observers
Dr Rosalind Roberts (MRC UKRI)
Stage 1 applications considered
NIHR206881: Promoting Accessibility in Clinical Trials (PRACTICALs): Development and pilot testing of an eLearning resource
Conflicts: Dr Anne Killett
Outcome: Invite to Stage 2
NIHR206811: Development of a core outcome set for revision hip and knee replacement
Conflicts: Professor Andrew Judge
Outcome: Reject
NIHR206851: Developing a National Monitoring System to Detect Teratogenic Medications
Conflicts: Professor Judith Rankin
Outcome: Reject
NIHR206897: Target trials for talking therapies to estimate their real-world effectiveness, cost-effectiveness, and inequalities in outcomes using causal inference techniques applied to NHS Talking Therapies real-world data: The Target Therapies quasi-experimental study
Conflicts: Ms Catherine Arundel, Professor Tom Sanders, Professor Sofia Dias, Professor Cindy Cooper (Direct COI), Professor Chris Gale
Outcome: Invite to Stage 2
NIHR206899: Development and validation of clinical tools for predicting outcome in newly diagnosed epilepsy
Conflicts: Professor Bridget Young, Professor Gary Collins, Professor Sofia Dias
Outcome: Invite to Stage 2
NIHR206907: Using secondary data to provide insights into risks and treatments for children and young people with anxiety and depression
Conflicts: Professor Andy Vail
Outcome: Reject
NIHR206818: Periodontal Treatment On Cardiovascular Disease Prevention: An Emulated Target Trial Approach
Conflicts: None
Outcome: Reject
NIHR206842: PROMISE: Principles of Engagement: Developing Methods to Increase Representation of Black Mothers in Maternal and Neonatal Healthcare Research
Conflicts: Professor Marcus Munafo
Outcome: Invite to Stage 2
NIHR206815: PROSPECT, a web-based resource promoting social inclusion in older people from LGBTQ+ communities: A co-design study with the public, primary healthcare and the third sector.
Conflicts: None
Outcome: Reject
NIHR206855:Development of reporting guidelines for the content of statistical analysis plans for cluster randomised trials
Conflicts: Professor Chris Gale, Professor William Hamilton, Professor Laura Gray
Outcome: Reject
NIHR206857: Individualised Risk of diabetes In women with a history of gestational diabetes to Support testing (IRIS)
Conflicts: None
Outcome: Reject
NIHR206853: An evaluation of patients' preferences for the surgical management of mitral valve repair: A discrete choice experiment
Conflicts: Professor Judith Rankin
Outcome: Reject
NIHR206880: Using Mendelian randomisation and Target trial emulation methods to better assess the causal effect of Mediterranean diet on multimorbidity in the UK population
Conflicts: Dr Anne Killett
Outcome: Reject
NIHR206864: Stoma Support Study II: Co-production, user-testing and evaluation of a digital intervention to support the prevention and self-management of distress experienced by young adults with a stoma due to inflammatory bowel disease (IBD)
Conflicts: Dr Anne Killett
Outcome: Reject
NIHR206820: Co-developing a service user centred communication tool for use in complex palliative and end of life care settings with minority groups
Conflicts: Professor Andy Vail
Outcome: Reject
NIHR206844: Improving sleep for hospital inpatients: Development and implementation of the ASLEEP toolkit
Conflicts: Professor Jos Latour, Professor Andrew Judge
Outcome: Invite to Stage 2
NIHR206854: Developing inclusive co-design tools for health-related co-design in partnership with minority ethnic communities.
Conflicts: Dr Lisa Hinton
Outcome: Invite to Stage 2
NIHR206866: How, why and in what contexts are interventions to improve primary care clinicians' communication with women patients effective? A realist review
Conflicts: Professor John Campbell, Professor Laura Gray, Dr Anne Killett
Outcome: Reject
NIHR206906: Evaluation of translation and INterpretation serVIces implemented by clinical Trials units (CTUs) to increase recruitment of Ethnic minority groups in pragmatic randomised controlled trials (INVITE study)
Conflicts: Professor Bridget Young, Professor Cindy Cooper, Professor Andrew Judge
Outcome: Invite to Stage 2
NIHR206918:Maternal mental health: an analysis of mental health experiences in primary and secondary care after birth complications/trauma
Conflicts: Professor William Hamilton, Dr Cath Quinn, Professor John Campbell, Professor Jos Latour
Outcome: Reject
NIHR206869:Healthcare service use by children and families after discharge from neonatal care
Conflicts: Professor Judith Rankin, Professor Richard Grieve, Professor Chris Gale, Professor Laura Gray
Outcome: Reject
NIHR206829: Reducing morbidity and mortality from infection during cancer treatment through OPTImising TEMPerature measurement (OPTITEMP)
Conflicts: Professor Gary Collins, Dr Lisa Hinton
Outcome: Reject
NIHR206825: Understanding the impact, needs, treatment and priorities of open fracture trauma in children (5-18yrs)
Conflicts: Professor Jos Latour, Professor Andrew Judge
Outcome: Reject
Outcomes Table
The table below displays the mean score for each application that was assessed in the research assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 4-6, although a score of 4-6 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.
In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 4.
Stage 1
| Score | Number of applications invited | Number of applications rejected |
|---|---|---|
| 5.0 - 6.0 | 1 | 0 |
| 4.0 - 4.9 | 6 | 0 |
| 3.0 - 3.9 | 0 | 7 |
| 2.0 - 2.9 | 0 | 8 |
| 1.0 - 1.9 | 0 | 1 |